Uppsala Reports editor
@UMCGlobalSafety
Pharmacovigilance is integral to ensuring medicines and vaccines safety for people, but what about our furry friends? Join us as we take a deep dive into veterinary PV.
Animals are a big part of our lives in many ways: from pets, to agriculture, and even as a means of transport and as a food source. Over the last couple of years, and even a few weeks ago, we are also reminded on how much animal health affects our own health and vice versa with the ever-present threat of zoonotic pathogens. How then, do we monitor the medicines and vaccines safety of our furry friends?
In this two-part episode of Drug Safety Matters, James Mount, Veterinary Pharmacovigilance assessor at the Swedish Medical Products Agency, and EU elected chair of the Pharmacovigilance Working Party for veterinary medicinal products, joins the show to talk about veterinary PV practice and its differences and similarities to human PV. Listen in to learn more on how comparable veterinary PV is to human PV, the kinds of adverse drug reactions reported in veterinary PV databases, and how exposure of humans to medicines for animals and vice versa impact their safety.
Uppsala Reports editor
@UMCGlobalSafety
UMC is at the heart of a concerted effort to develop a panacea for a global headache: How to describe medicines consistently.
21 May 2026
What if risk management began earlier? DRMPs serve as a framework for safety thinking in clinical development and support better benefit–risk decision-making.
04 March 2026
Safety systems do not need to be complex to be effective. Shanthi Pal explains the thinking behind the Global Smart Pharmacovigilance Strategy, and how it can be implemented.
17 December 2025